Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSGenetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants.Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactorRegulation of glycogen synthase kinase-3 during bipolar mania treatmentGlycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male ratsGrowth retardation and altered autonomic control in mice lacking brain serotoninA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsThe 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouseReview of pharmacological treatment in mood disorders and future directions for drug development.Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviourRegulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disordersIndividual Differences in Behavioural Despair Predict Brain GSK-3beta Expression in Mice: The Power of a Modified Swim Test.Molecular genetics of mouse serotonin neurons across the lifespan.A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental healthStimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutationHaploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.New therapeutic targets for mood disordersSerotonin deficiency alters susceptibility to the long-term consequences of adverse early life experience.Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis.Convergent effects of mouse Pet-1 deletion and human PET-1 variation on amygdala fear and threat processingNeurodevelopment in schizophrenia: the role of the wnt pathways.Behavioral and pharmacogenetics of aggressive behavior.GSK-3: Functional Insights from Cell Biology and Animal Models.Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.Is glycogen synthase kinase-3 a central modulator in mood regulation?Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsThe serotonergic system: its role in pathogenesis and early developmental treatment of autism.Abnormalities in brain structure and behavior in GSK-3alpha mutant miceRGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivityA functional Tph2 C1473G polymorphism causes an anxiety phenotype via compensatory changes in the serotonergic system.Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviourDeficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.Sex differences in response to chronic mild stress and congenital serotonin deficiencyGenetic mapping of escalated aggression in wild-derived mouse strain MSM/Ms: association with serotonin-related genes.Regulating prefrontal cortex activation: an emerging role for the 5-HT₂A serotonin receptor in the modulation of emotion-based actions?Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges.
P2860
Q21129334-17232D6A-3119-4266-946B-F13AAAEE0462Q21144229-A3AFFFCD-D358-40A7-A564-31060D59AC9AQ24305619-099C37C1-6BC5-4A27-AEFD-A4C5668FD6E0Q24594534-EC370362-55E0-42E0-BE5F-EDAEFCAB39DAQ24629780-42860AEC-9D1E-49E7-B90A-CBF5167EFDB2Q24658409-7BE05430-90CA-40AC-9F84-491ADE690777Q26741164-02BE1554-0486-4C9D-999C-F793E10D4EB0Q26849351-1DF932D8-2CFD-4699-99BC-791DAE83BF51Q26853509-4E71C778-597D-4C04-ACBE-79C20BCCF84DQ26865831-AA7A1F97-AAC0-4B14-B059-C771F0E1DF8EQ27027115-34433CE0-473B-42A2-9B6F-8BF39462E3C7Q27312769-A66834FA-956B-422B-8CEE-36D84B7C140AQ27691374-BF0E1300-8F9E-4458-8BB7-E52A9EC97BD9Q28118906-CD8AB34A-FFF5-432D-921E-804DFE139947Q28301428-26C47F5C-6320-42E2-BC9B-13E5158A577FQ28508076-C319C4C1-E319-4D32-8C66-E9C10306C2B5Q28743068-58ADB1F6-6A82-43DF-92F1-A82A2BF9C31FQ30389942-C8D35CF5-35CF-4DC6-BD68-E3C6D7752575Q30395001-BFBFAB7C-2152-4DE2-AE27-DD02028E93ABQ30408186-0C09826E-F5E7-494F-AF2D-3F16933B8EADQ30414460-35168BC7-EF56-46B3-8205-0E5A8CE2BF29Q30423899-9766E21B-AD94-4E6B-AE42-C11BBD846CA5Q30442237-EB8589FC-3346-4F1B-BDA1-AB0F493F287AQ30445754-5C843BB9-2F5D-43D7-B73E-C5552A1F95BAQ30472813-DB183D17-C549-430E-8458-AAB068F31CCFQ30474415-7C8FB498-B0D9-4AD4-8D49-E2E30B1230ECQ30475816-D2CB7D2C-DB96-43FC-A756-02E16D0339E1Q30476813-696D5859-0F11-4B64-8E7F-CD8BBE3AB526Q30484882-8AF741BC-8DBE-4776-8E6A-7909C8D6B584Q30485018-C06DF8CA-BACC-4481-943E-0AE035789FDBQ30495060-D59CDC0C-F91F-4BFD-9BA0-400767566EE9Q30495108-0D254F64-637E-493C-8A13-8E5F7FE52B16Q30515538-694B5736-3787-4EB3-8895-55EECB39C5D8Q30521113-EB9A8836-C37A-48B0-AE22-C79FAE54C3F4Q30522548-E22E433F-BA35-4F39-9D14-94986A052F13Q30531298-D0DCE4CF-4BFF-43FB-BA12-2EBA0ED92A83Q30571260-38FF4105-652B-42B2-A36E-1B7581498048Q30580450-3AC32B3F-3C35-4C29-8F1B-6AA490A2C22EQ30630506-61F4B838-BD26-4E9E-A046-C4D72DC82693Q33570161-7BA09CEC-FAA9-4115-869A-D124530A60F0
P2860
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@ast
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@en
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@nl
type
label
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@ast
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@en
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@nl
prefLabel
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@ast
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@en
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@nl
P2093
P2860
P356
P1476
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
@en
P2093
Marc G Caron
Michael J Cools
Ramona M Rodriguiz
Tatyana D Sotnikova
William C Wetsel
Xiaodong Zhang
P2860
P304
P356
10.1073/PNAS.0711496105
P407
P577
2008-01-22T00:00:00Z